Farringdon Capital Ltd. Invests $250,000 in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Farringdon Capital Ltd. acquired a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 3,198 shares of the company's stock, valued at approximately $250,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Kestra Investment Management LLC acquired a new position in Prestige Consumer Healthcare during the fourth quarter worth $27,000. CIBC Private Wealth Group LLC grew its holdings in shares of Prestige Consumer Healthcare by 48.9% in the fourth quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock valued at $34,000 after purchasing an additional 152 shares during the period. Headlands Technologies LLC purchased a new stake in shares of Prestige Consumer Healthcare during the 4th quarter valued at approximately $40,000. GAMMA Investing LLC lifted its stake in shares of Prestige Consumer Healthcare by 18.9% in the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company's stock valued at $108,000 after purchasing an additional 220 shares during the last quarter. Finally, Huntington National Bank raised its stake in shares of Prestige Consumer Healthcare by 133.2% in the 4th quarter. Huntington National Bank now owns 1,481 shares of the company's stock valued at $116,000 after acquiring an additional 846 shares during the period. 99.95% of the stock is owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Stock Performance

NYSE:PBH remained flat at $79.53 during mid-day trading on Friday. The company had a trading volume of 65,438 shares, compared to its average volume of 286,026. The company has a market capitalization of $3.94 billion, a price-to-earnings ratio of 18.62, a price-to-earnings-growth ratio of 2.69 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a 1 year low of $62.35 and a 1 year high of $90.04. The firm's 50 day moving average price is $83.69 and its 200 day moving average price is $80.39. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its earnings results on Thursday, February 6th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. As a group, equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently commented on PBH. StockNews.com downgraded shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research note on Tuesday, April 8th. Canaccord Genuity Group lifted their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a "buy" rating in a report on Friday, February 7th. DA Davidson raised their target price on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a report on Friday, February 7th. Oppenheimer upped their price target on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a report on Thursday, February 13th. Finally, Royal Bank of Canada lifted their target price on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the stock a "sector perform" rating in a research report on Friday, March 21st. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, Prestige Consumer Healthcare has an average rating of "Hold" and an average target price of $93.33.

Insider Buying and Selling at Prestige Consumer Healthcare

In other news, SVP Mary Beth Fritz sold 1,678 shares of the business's stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the transaction, the senior vice president now directly owns 17,157 shares in the company, valued at approximately $1,544,130. The trade was a 8.91 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.60% of the company's stock.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.